Using in vitro assays, experimental downregulation of LAT1 has been demonstrated to suppress CCA cell invasion and migration, which suggests that LAT1 constitutes a potential therapeutic target for treating CCA [41]. The gene discussed is SLC7A5; the disease is cholangiocarcinoma.